The role of broncho-alveolar lavage in prevention of ventilator associated pneumonia and prediction of prognosis in mechanically ventilated trauma patients | ||||
| The Egyptian Journal of Intensive Care and Emergency Medicine | ||||
| Volume 5, Issue 2, June 2025, Page 55-77 PDF (972.46 K) | ||||
| Document Type: Original papers | ||||
| DOI: 10.21608/jicem.2025.431119 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Asmaa Abdelhakim   1; Mai M. Mahran1; Mohamed H. Fouda2; Mohamed Torky3; Mohamed S. Hantera3; Ahmed Saber4; Ahmed I. Eid1
| ||||
| 1Emergency & Traumatology Department, Faculty of Medicine, Tanta University, Egypt. | ||||
| 2Department of Clinical Pathology, Faculty of Medicine, Tanta University, Egypt. | ||||
| 3Chest Department, Faculty of Medicine, Tanta University, Egypt. | ||||
| 4Department of Anesthesiology & Intensive Care, Faculty of Medicine, Tanta University, Egypt. | ||||
| Abstract | ||||
| Purpose: The effect of early vs late broncho-alveolar lavage (BAL) on incidence of ventilator associated pneumonia (VAP), besides the cytokines level in both BAL fluids (BALF) and blood on patients’ outcome. Methods: Seventy mechanically ventilated trauma patients were enrolled and allocated into two equal groups early BAL (Group I) and late BAL (Group II). BALF and blood samples were obtained simultaneously. Samples were submitted for microbiological tests and determination of Interleukin 6 (IL6) and interleukin 8 (IL8) levels. Results: VAP incidence was significantly lower in group I (28.6%) than group II (60%) (P =0.008). IL6 in BALF was significantly different between both BAL groups (P=0.037) and VAP and non VAP cases (P=0.001), While, IL8 in BALF showed insignificant difference between similar groups. In a regression analysis, IL6 in BALF was a predictor for VAP development (OR 1.16, 95.0% CI: 1.021-1.218, P=0.004). BALF level of IL6 and IL8 showed significant difference between survivors and non-survivors (P=0.004) and (P=0.03) respectively. Conclusion: Early BAL reduces the incidence of VAP and improves the outcome of mechanically ventilated trauma patients, the use of IL6 and IL8 levels in BALF in combination with other biomarkers is a promising avenue for better VAP management. | ||||
| Keywords | ||||
| Trauma; Ventilator associated pneumonia; Broncho-alveolar lavage; Interleukin 6 (IL6); and interleukin 8 (IL8) | ||||
| References | ||||
|
[1] Spalding MC, Cripps MW, Minshall CT. Ventilator-Associated Pneumonia: New Definitions. Crit Care Clin. 2017 Apr;33(2):277-292. doi: 10.1016/j.ccc.2016.12.009
[2] Kalanuria AA, Ziai W, Mirski M. Erratum to: Ventilator-associated pneumonia in the ICU. Crit Care. 2016 Jan 28;20:29. doi: 10.1186/s13054-016-1206-8.
[3] Colombo SM, Palomeque AC, Li Bassi G. The zero-VAP sophistry and controversies surrounding prevention of ventilator-associated pneumonia. Intensive Care Med. 2020 Feb;46(2):368-371. doi: 10.1007/s00134-019-05882-w.
[4] Núñez SA, Roveda G, Zárate MS, Emmerich M, Verón MT. Ventilator-associated pneumonia in patients on prolonged mechanical ventilation: description, risk factors for mortality, and performance of the SOFA score. J Bras Pneumol. 2021 Jun 23;47(3):e20200569. doi: 10.36416/1806-3756/e20200569.
[5] Dupont H, Mentec H, Sollet JP, Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001 Feb;27(2):355-62. doi: 10.1007/s001340000640.
[6] Jovanovic B, Milan Z, Djuric O, Markovic-Denic L, Karamarkovic A, Gregoric P, Doklestic K, Avramovic J, Velickovic J, Bumbasirevic V. Twenty-Eight-Day Mortality of Blunt Traumatic Brain Injury and Co-Injuries Requiring Mechanical Ventilation. Med Princ Pract. 2016;25(5):435-41. doi: 10.1159/000447566.
[7] Alves JNB, Soares LG, Baratieri T, de Brito É, Pelazza PBB, Zanoti-Jeronymo DV, et al. Pneumonia in patients hospitalized for trauma under intensive care* pneumonia em pacientes hospitalizados por traumas sob tratamento intensivo* neumonía en pacientes hospitalizados por trauma en tratamiento intensivo. J Nurs UFPE on line. 2021;15:20-9.
[8] Wang Z, Pu Q, Huang C, Wu M. Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation. Adv Exp Med Biol. 2021;1303:333-350. doi: 10.1007/978-3-030-63046-1_18.
[9] Robba C, Rebora P, Banzato E, Wiegers EJA, Stocchetti N, Menon DK, Citerio G; Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Participants and Investigators. Incidence, Risk Factors, and Effects on Outcome of Ventilator-Associated Pneumonia in Patients With Traumatic Brain Injury: Analysis of a Large, Multicenter, Prospective, Observational Longitudinal Study. Chest. 2020 Dec;158(6):2292-2303. doi: 10.1016/j.chest.2020.06.064.
[10] Zha L, Zhang D, Pan L, Ren Z, Li X, Zou Y, Li S, Luo S, Yang G, Tefsen B. Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study. Infect Dis Ther. 2021 Dec;10(4):2415-2429. doi: 10.1007/s40121-021-00516-5.
[11] Downes, Kevin & Bouso, Jennifer & Planet, Paul. Bronchoalveolar Lavage: Microbial Evaluation: Bacteriology, Virology, Parasitology, Mycology, and Airway Microbiome. Diagnostic and Interventional Bronchoscopy in Children Springer; 2021. p. 81-126. DOI:10.1007/978-3-030-54924-4_9
[12] Russo A, Venditti M, Ceccarelli G, Mastroianni CM, d'Ettorre G. Early antibiotic treatment in emergency department: the critical balance. Intern Emerg Med. 2021 Oct;16(7):1743-1745. doi: 10.1007/s11739-021-02779-9.
[13] Lowe, Jonner & Singh, Jaspal. (2021). Diagnostic and Therapeutic Bronchoscopy. Interventional Critical Care. Springer; 2021. p. 79-86. DOI:10.1007/978-3-030-64661-5_9
[14] Stahl DL, Richard KM, Papadimos TJ. Complications of bronchoscopy: A concise synopsis. Int J Crit Illn Inj Sci. 2015 Jul-Sep;5(3):189-95. doi: 10.4103/2229-5151.164995.
[15] Holloway TL, Rani M, Cap AP, Stewart RM, Schwacha MG. The association between the Th-17 immune response and pulmonary complications in a trauma ICU population. Cytokine. 2015 Dec;76(2):328-333. doi: 10.1016/j.cyto.2015.09.003.
[16] Zilberberg MD, Shorr AF. Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S131-5. doi: 10.1086/653062.
[17] Linssen CF, Bekers O, Drent M, Jacobs JA. C-reactive protein and procalcitonin concentrations in bronchoalveolar lavage fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem. 2008 May;45(Pt 3):293-8. doi: 10.1258/acb.2007.007133.
[18] Jovanovic B, Milan Z, Markovic-Denic L, Djuric O, Radinovic K, Doklestic K, Velickovic J, Ivancevic N, Gregoric P, Pandurovic M, Bajec D, Bumbasirevic V. Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. Int J Infect Dis. 2015 Sep;38:46-51. doi: 10.1016/j.ijid.2015.07.005.
[19] Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med. 2020 Feb;46(2):245-265. doi: 10.1007/s00134-019-05866-w.
[20] Renaud C, Kollef MH. Classical and Molecular Techniques to Diagnose HAP/VAP. Semin Respir Crit Care Med. 2022 Apr;43(2):219-228. doi: 10.1055/s-0041-1739359.
[21] Wunderink RG, Waterer G. Advances in the causes and management of community acquired pneumonia in adults. BMJ. 2017 Jul 10;358:j2471. doi: 10.1136/bmj.j2471.
[22] Klompas M. Prevention of Intensive Care Unit-Acquired Pneumonia. Semin Respir Crit Care Med. 2019 Aug;40(4):548-557. doi: 10.1055/s-0039-1695783.
[23] Wang KW, Chen HJ, Lu K, Liliang PC, Huang CK, Tang PL, Tsai YD, Wang HK, Liang CL. Pneumonia in patients with severe head injury: incidence, risk factors, and outcomes. J Neurosurg. 2013 Feb;118(2):358-63. doi: 10.3171/2012.10.JNS127.
[24] Yepes D, Molina F, Ortiz G, Aguirre R. Factores de riesgo asociados a neumonía en pacientes con trauma craneoencefálico grave [Risk factors associated with the presence of pneumonia in patients with brain injury]. Biomedica. 2009 Jun;29(2):253-9. Spanish. PMID: 20128350.
[25] Miri M, Mofrad Taheri N and Soloki M. Survey of the Complications and Clinical Outcomes in Patients with Ventilator-Associated Pneumonia in Two Groups with and without Traumatic Brain Injury Admitted to ICU. J Mil Med. 2022;18(1):307-14.
[26] Younan D, Delozier SJ, Adamski J, Loudon A, Violette A, Ustin J, Tinkoff G, Moorman ML, McQuay N; UHRISES Research Consortium. Factors Predictive of Ventilator-associated Pneumonia in Critically Ill Trauma Patients. World J Surg. 2020 Apr;44(4):1121-1125. doi: 10.1007/s00268-019-05286-3.
[27] Ranjan N, Ranjan K, Chaudhary U and Chaudhry D. Antimicrobial resistance in bacteria causing ventilator-associated pneumonia in a tertiary care hospital: one year prospective study. Int J Res Med Sci. 2014;2(1):228-33. doi:10.5455/2320-6012.
[28] Golia S, K T S, C L V. Microbial profile of early and late onset ventilator associated pneumonia in the intensive care unit of a tertiary care hospital in bangalore, India. J Clin Diagn Res. 2013 Nov;7(11):2462-6. doi: 10.7860/JCDR/2013/6344.3580.
[29] Shorr AF, Sherner JH, Jackson WL, Kollef MH. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2005 Jan;33(1):46-53. doi: 10.1097/01.ccm.0000149852.32599.31.
[30] Wang F, He B. [The role of endotracheal aspirate culture in the diagnosis of ventilator-associated pneumonia: a meta analysis]. Zhonghua Jie He He Hu Xi Za Zhi. 2013 Jan;36(1):27-32. Chinese.
[31] El Solh AA, Akinnusi ME, Pineda LA, Mankowski CR. Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia. Crit Care. 2007;11(3):R57. doi: 10.1186/cc5917.
[32] de Jaeger A, Litalien C, Lacroix J, Guertin MC, Infante-Rivard C. Protected specimen brush or bronchoalveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: a meta-analysis. Crit Care Med. 1999 Nov;27(11):2548-60. doi: 10.1097/00003246-199911000-00037.
[33] Rea-Neto A, Youssef NC, Tuche F, Brunkhorst F, Ranieri VM, Reinhart K, Sakr Y. Diagnosis of ventilator-associated pneumonia: a systematic review of the literature. Crit Care. 2008;12(2):R56. doi: 10.1186/cc6877.
[34] Kollef MH, Bock KR, Richards RD, Hearns ML. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med. 1995 May 15;122(10):743-8. doi: 10.7326/0003-4819-122-10-199505150-00002.
[35] Kamboh UA, Choudhary N, Manzoor M, Raza A, Naseer-ud-Din G and Rauf MA. Impact of Bronchoscopic Lavage and Aggressive Chest Physiotherapy on Clinical Pulmonary Infection Score of Patients of Severe Traumatic Brain Injury. Pak J Neurol Surg. 2022;26(2):327-33. DOI: https://doi.org/10.36552/pjns.v26i2.698
[36] Loftus TJ, Lemon SJ, Nguyen LL, Voils SA, Brakenridge SC, Jordan JR, Croft CA, Smith RS, Moore FA, Efron PA, Mohr AM. Early bronchoalveolar lavage for intubated trauma patients with TBI or chest trauma. J Crit Care. 2017 Jun;39:78-82. doi: 10.1016/j.jcrc.2017.02.010.
[37] Chen W, Zhong K, Guan Y, Zhang HT, Zhang H, Pan T, Pan J, Wang DJ. Evaluation of the significance of interleukin-6 in the diagnosis of postoperative pneumonia: a prospective study. BMC Cardiovasc Disord. 2022 Jul 7;22(1):306. doi: 10.1186/s12872-022-02744-0.
[38] Meduri GU, Kohler G, Headley S, Tolley E, Stentz F, Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest. 1995 Nov;108(5):1303-14. doi: 10.1378/chest.108.5.1303.
[39] Conway Morris A, Kefala K, Wilkinson TS, Moncayo-Nieto OL, Dhaliwal K, Farrell L, Walsh TS, Mackenzie SJ, Swann DG, Andrews PJ, Anderson N, Govan JR, Laurenson IF, Reid H, Davidson DJ, Haslett C, Sallenave JM, Simpson AJ. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax. 2010 Mar;65(3):201-7. doi: 10.1136/thx.2009.122291.
[40] Seinen J, Engelke R, Abdullah MR, Voß F, Michalik S, Dhople VM, Dieperink W, de Smet AMGA, Völker U, van Dijl JM, Schmidt F, Hammerschmidt S. Sputum Proteome Signatures of Mechanically Ventilated Intensive Care Unit Patients Distinguish Samples with or without Anti-pneumococcal Activity. mSystems. 2021 Mar 2;6(2):e00702-20. doi: 10.1128/mSystems.00702-20.
[41] Antcliffe DB, Wolfer AM, O'Dea KP, Takata M, Holmes E, Gordon AC. Profiling inflammatory markers in patients with pneumonia on intensive care. Sci Rep. 2018 Oct 3;8(1):14736. doi: 10.1038/s41598-018-32938-6.
[42] Bendib I, Beldi-Ferchiou A, Schlemmer F, Surenaud M, Maitre B, Plonquet A, Carteaux G, Razazi K, Godot V, Hüe S, Mekontso Dessap A, de Prost N. Alveolar compartmentalization of inflammatory and immune cell biomarkers in pneumonia-related ARDS. Crit Care. 2021 Jan 9;25(1):23. doi: 10.1186/s13054-020-03427-y.
[43] Ware LB, Koyama T, Billheimer DD, Wu W, Bernard GR, Thompson BT, Brower RG, Standiford TJ, Martin TR, Matthay MA; NHLBI ARDS Clinical Trials Network. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest. 2010 Feb;137(2):288-96. doi: 10.1378/chest.09-1484.
[44] Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet. 1993 Mar 13;341(8846):643-7. doi: 10.1016/0140-6736(93)90416-e.
| ||||
|
Statistics Article View: 102 PDF Download: 59 |
||||
